| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Medpace Holdings, Inc.
13D/A
Amendment 24
MEDP · 58506Q109
|
19.1% |
9/28/2026
Event 9/24/2026
|
|||
| August J. Troendle | 19.1% | ||||
| Medpace Investors, LLC | 16.8% | ||||
|
Medpace Holdings, Inc.
13D/A
Amendment 23
MEDP · 58506Q109
|
20.0% |
12/1/2025
Event 11/26/2025
|
|||
| August J. Troendle | 20.0% | ||||
| Medpace Investors, LLC | 16.6% | ||||
|
Medpace Holdings, Inc.
13D/A
Amendment 22
MEDP · 58506Q109
|
19.5% |
3/11/2025
Event 3/7/2025
|
|||
| August J. Troendle | 19.5% | ||||
| Medpace Investors, LLC | 15.3% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.